Pfizer and BioNTech Initiate Rolling Submission of Biologics License Application for U.S. FDA Approval of Their COVID 19 Vaccine

NEW YORK& MAINZ, Germany--(BUSINESS WIRE) May 07, 2021 -- Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced the initiation of a Biologics License Application (BLA) with the U.S. Food and Drug Administration (FDA) for...
Source: Drugs.com - Clinical Trials - Category: Pharmaceuticals Source Type: clinical trials